Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON54649Recruiting
Open-label trial of prednisone, vincristine, etoposide, doxorubicin, cyclophosphamide and 2 more in classical Hodgkin lymphoma (cHL) (3 arms), sponsored by Vrije University Medical Center. Primary endpoints: Anti-Mullerian hormone and Total motile sperm count. Started Jan 2017; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON54649.